Metabolomic profiles for primary progressive multiple sclerosis stratification and disease course monitoring
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Frontiers in Human Neuroscience 12 (2018) Art. 226 DOI: 10.3389/fnhum.2018.00226
Postprints der Universität Potsdam : Mathematisch-Naturwissenschaftliche Reihe ; 694
- Ereignis
-
Veröffentlichung
- (wo)
-
Potsdam
- (wer)
-
Universität Potsdam
- (wann)
-
2019
- Urheber
-
Stoessel, Daniel
Stellmann, Jan-Patrick
Willing, Anne
Behrens, Birte
Rosenkranz, Sina C.
Hodecker, Sibylle C.
Stürner, Klarissa H.
Reinhardt, Stefanie
Fleischer, Sabine
Deuschle, Christian
Maetzler, Walter
Berg, Daniela
Heesen, Christoph
Walther, Dirk
Schauer, Nicolas
Friese, Manuel A.
Pless, Ole
- URN
-
urn:nbn:de:kobv:517-opus4-426307
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:51 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Stoessel, Daniel
- Stellmann, Jan-Patrick
- Willing, Anne
- Behrens, Birte
- Rosenkranz, Sina C.
- Hodecker, Sibylle C.
- Stürner, Klarissa H.
- Reinhardt, Stefanie
- Fleischer, Sabine
- Deuschle, Christian
- Maetzler, Walter
- Berg, Daniela
- Heesen, Christoph
- Walther, Dirk
- Schauer, Nicolas
- Friese, Manuel A.
- Pless, Ole
- Universität Potsdam
Entstanden
- 2019
Ähnliche Objekte (12)
Primary progressive multiple sclerosis
Primary progressive multiple sclerosis (PPMS) – cerebrospinal fluid (CSF) profile
CSF profile in primary progressive multiple sclerosis : re-exploring the basics
Cerebrospinal fluid biomarkers in relation to MRZ reaction status in primary progressive multiple sclerosis
A language-based sum score for the course and therapeutic intervention in primary progressive aphasia
Quantifying disease progression in primary progressive aphasia
Speech motor profiles in primary progressive aphasia
Ocrelizumab treatment in patients with primary progressive multiple sclerosis: short-term safety results from a compassionate use programme in Germany
Protein Profiling of Primary Human Samples for Pathway Analysis and Patient Stratification
Analysing the course of multiple sclerosis with segmented regression models
Glial activation markers in CSF and serum from patients with primary progressive multiple sclerosis: potential of serum GFAP as disease severity marker?
Prognostic value of reported chest pain for cardiovascular risk stratification in primary care
Primary progressive multiple sclerosis
Primary progressive multiple sclerosis (PPMS) – cerebrospinal fluid (CSF) profile
CSF profile in primary progressive multiple sclerosis : re-exploring the basics
Cerebrospinal fluid biomarkers in relation to MRZ reaction status in primary progressive multiple sclerosis
A language-based sum score for the course and therapeutic intervention in primary progressive aphasia
Quantifying disease progression in primary progressive aphasia
Speech motor profiles in primary progressive aphasia
Ocrelizumab treatment in patients with primary progressive multiple sclerosis: short-term safety results from a compassionate use programme in Germany
Protein Profiling of Primary Human Samples for Pathway Analysis and Patient Stratification
Analysing the course of multiple sclerosis with segmented regression models
Glial activation markers in CSF and serum from patients with primary progressive multiple sclerosis: potential of serum GFAP as disease severity marker?
Prognostic value of reported chest pain for cardiovascular risk stratification in primary care
Primary progressive multiple sclerosis
Primary progressive multiple sclerosis (PPMS) – cerebrospinal fluid (CSF) profile
CSF profile in primary progressive multiple sclerosis : re-exploring the basics
Cerebrospinal fluid biomarkers in relation to MRZ reaction status in primary progressive multiple sclerosis
A language-based sum score for the course and therapeutic intervention in primary progressive aphasia
Quantifying disease progression in primary progressive aphasia
Speech motor profiles in primary progressive aphasia
Ocrelizumab treatment in patients with primary progressive multiple sclerosis: short-term safety results from a compassionate use programme in Germany
Protein Profiling of Primary Human Samples for Pathway Analysis and Patient Stratification
Analysing the course of multiple sclerosis with segmented regression models
Glial activation markers in CSF and serum from patients with primary progressive multiple sclerosis: potential of serum GFAP as disease severity marker?